|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature
|
|
|
|
Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it's not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough to run, expensive, and groups …
|
|
|
|
|
|
|
|
I found something Elon Musk & I agree on: pushing back on anti-aging bluster
|
|
|
|
Would you guess that Elon Musk might be into using biotechnology in a high-profile way to try to live far longer than usual, say to age 150? That would have been my assumption. There are countless things about Elon Musk that I really don't like. I also don't see many issues on which we are in sync. However, there is …
|
|
|
|
|
|
